ReviewEuropean cardiology2018

Treatment Selection in Pulmonary Arterial Hypertension: Phosphodiesterase Type 5 Inhibitors versus Soluble Guanylate Cyclase Stimulator.

Hiroshi WatanabePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.